Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001255907 | SCV002171318 | pathogenic | Alstrom syndrome | 2023-11-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg3659*) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Alstrom syndrome (PMID: 16720663). ClinVar contains an entry for this variant (Variation ID: 977960). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001255907 | SCV002798712 | pathogenic | Alstrom syndrome | 2021-09-13 | criteria provided, single submitter | clinical testing | |
Laboratory of Genetics in Ophthalmology, |
RCV001255907 | SCV001432511 | pathogenic | Alstrom syndrome | no assertion criteria provided | research |